NNNN
Anbio Biotechnology Class A Ordinary Shares
There isn't enough reported data to score NNNN yet.
NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
NNNN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Stable | |
| Strong |
NNNN's profitability and balance sheet are currently strong, and its cash flow is stable. There isn't enough data to rate its revenue.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NNNN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 26x | $3.80 | — |
| Cheap | 42x | $6.24 | +64% |
| Fair | 162x | $24.23 | +538% |
| Expensive | 420x | $63.06 | +1559% |
Historical ranges are pointers, not guarantees.
NNNN's PE is 26x, but its earnings don't support one, so it isn't a reliable read right now.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO has the edge over NNNN in the historical PE scenario, which offers more potential upside but is not a forecast.
NNNN Forward outlook
There aren't enough analyst estimates for NNNN to show an outlook.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
NNNN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.15 | +150% |
| Q4 2024 | $0.06 | -14% |
| Q4 2023 | $0.07 | -73% |
NNNN has the edge over NVO in the latest year-over-year earnings comparison.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO's earnings per share have climbed steadily: $3.89 over the past year, up 4.9% from the year before, and higher year over year every quarter since late 2020.
NNNN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $8.6M | +5.6% |
| Q4 2024 | $8.2M | +107% |
| Q4 2023 | $4M | +39% |
| Q3 2023 | $1.8M | -36% |
| Q2 2023 | $3.3M | -63% |
| Q1 2023 | $1.5M | -83% |
NNNN has the stronger quarterly revenue trend. Revenue is up 162% for NNNN versus up 2.1% for NVO.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 67% | +20 points |
| Q4 2024 | 24% | -22 points |
| Q4 2023 | 15% | +14 points |
| Q3 2023 | 15% | +14 points |
| Q2 2023 | 46% | -11 points |
| Q1 2023 | 46% | -11 points |
| Q4 2022 | 1.2% | N/A |
| Q3 2022 | 0.6% | N/A |
NNNN's operating margin was 67% last quarter, up 20 points from the same quarter a year ago, near the top of its range since 2022.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO's operating margin was 34% last quarter, down 9 points from the same quarter a year ago, near the bottom of its range since 2019.
NNNN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2023 | -$1.3M | -140% |
| Q3 2023 | -$616.6K | -137% |
| Q2 2023 | $2.3M | +324% |
| Q1 2023 | $1.1M | +96% |
NVO has the stronger cash trend. Its trailing FCF is down 14% versus its history, compared with NNNN at down 79%.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO still generates free cash flow, though less than at its 2026 peak: $7.3B over the past year.
NNNN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +1.4M shares |
| 1 year | +3.3% | +1.4M shares |
NNNN has 44M diluted shares, up 3.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over NNNN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
NNNN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -4.1x | Net Cash |
| Q2 2023 | -6.7x | Net Cash |
| Q4 2022 | -0.6x | Net Cash |
NNNN has more cash than debt.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
NNNN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.4 | Neutral |
| Stochastic | 5.5 | Oversold |
NNNN's weekly RSI is 32 (neutral) and its Stochastic is 6 (oversold).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
NNNN PE vs Healthcare Sector
| Metric | NNNN | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 26x | Same PE |
| PE % | 4 | 72 | 68 pts below |
NNNN is trading at 26x earnings, in line with the Healthcare sector's median of 26x, though its earnings don't support one.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over NNNN on valuation relative to its sector.
NNNN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 12% below |
| 20 week MA | $6.89 | 45% below |
| 50 week MA | $18.7 | 80% below |
NVO has stronger trend alignment. NNNN is above 0 of 3 weekly averages versus NVO above 1 of 5.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
NNNN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $5.77 | $33.5 | +481% |
| 2026 YTD | $33.5 | $3.80 | -89% |
NNNN has finished every year since 2025 higher, and it's down 89% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over NNNN on returns for 2026, with the stronger performance.